BioSpace News Archive

Rational Vaccines today announced the launch of a clinical trial designed to investigate the disease burden of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in patients with HIV infection.

Biomea Fusion, Inc. announced that the company has been selected for addition to the NASDAQ Biotechnology Index, effective prior to market open on Monday, December 20, 2021.

Sirius Medical, a leader in tumor navigation technology, announced today the closing of its second round of series A financing.

Oravax’s oral vaccine targets three surface proteins, making it potentially more effective against current and future variants.

Klox Technologies Inc. (Klox, or the Company), the leading provider of Fluorescent Light Energy (FLE)-based Systems for treating diseases and conditions affecting the skin and soft tissues, announces that the United States Food and Drug Administration (FDA) has granted the Company De Novo clearance for the LumiHeal® System.

Phosplatin Therapeutics Inc. today announced that it has completed a $37 million Series A financing.

ImmunoGenesis announced the appointment of seasoned industry veteran Charles Schweizer , PhD, as Senior Vice President of Clinical Development.

Artio Medical, Inc. today announced that distinguished neurovascular and peripheral vascular interventional radiologist, Blaise W. Baxter, MD, FRCPC, FSNIC, has joined the company’s leadership team as Vice President of Neurovascular and Peripheral Vascular Interventions.

Cognito Therapeutics announced today the appointment of Jennifer Newberger as Vice President, Head of Regulatory Affairs and Compliance.

Cellworks Group, Inc., today announced the results from two clinical studies using the Cellworks Biosimulation Platform and Computational Omics Biology Model (CBM) to predict therapy response for individual MDS patients were featured in two poster presentations at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition held December 11-14, 2021 in Atlanta, Georgia.